{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:50:58Z","timestamp":1791366658152,"version":"4.3.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"41","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173226"],"award-info":[{"award-number":["82173226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304521"],"award-info":[{"award-number":["82304521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ23H160050"],"award-info":[{"award-number":["LQ23H160050"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,28]]},"DOI":"10.1038\/s41388-026-03968-6","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:12:38Z","timestamp":1787760758000},"page":"4406-4419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SEC14L2 contributes to tumor progression by enhancing USP5-driven RBM3 deubiquitination in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"45","author":[{"given":"Zengyu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanshuai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyao","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-4627","authenticated-orcid":false,"given":"Hongxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2578-3104","authenticated-orcid":false,"given":"Chenghong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"3968_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA: A Cancer J Clin. 2025;75:10\u201345.","DOI":"10.3322\/caac.21871"},{"key":"3968_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40314-w","volume":"14","author":"M Xue","year":"2023","unstructured":"Xue M, Zhu Y, Jiang Y, Han L, Shi M, Su R, et al. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment. Nat Commun. 2023;14:4600.","journal-title":"Nat Commun"},{"key":"3968_CR3","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A, Koerkamp BG, Seufferlein T, Wilmink JW, et al. Pancreatic cancer. Lancet. 2025;405:1182\u2013202.","journal-title":"Lancet"},{"key":"3968_CR4","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1016\/S1470-2045(13)70172-4","volume":"14","author":"W Hartwig","year":"2013","unstructured":"Hartwig W, Werner J, J\u00e4ger D, Debus J, B\u00fcchler MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol. 2013;14:e476\u201385.","journal-title":"Lancet Oncol"},{"key":"3968_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163:386\u2013402.e381.","journal-title":"Gastroenterology"},{"key":"3968_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115925","volume":"44","author":"Y Su","year":"2025","unstructured":"Su Y, Wei F, Li S, Qi J, Lin G, Li G, et al. Cingulin is an RNA-binding protein promoting pancreatic cancer through enhancing importin 7-mediated phospho-ERK nuclear translocation. Cell Rep. 2025;44:115925.","journal-title":"Cell Rep"},{"key":"3968_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1001\/jamasurg.2019.3337","volume":"154","author":"RP Jones","year":"2019","unstructured":"Jones RP, Psarelli EE, Jackson R, Ghaneh P, Halloran CM, Palmer DH, et al. Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the espac-4 randomized adjuvant chemotherapy trial. JAMA Surg. 2019;154:1038\u201348.","journal-title":"JAMA Surg"},{"key":"3968_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1053\/j.gastro.2024.05.028","volume":"167","author":"CS Leonhardt","year":"2024","unstructured":"Leonhardt CS, Gustorff C, Klaiber U, Le Blanc S, Stamm TA, Verbeke CS, et al. Prognostic factors for early recurrence after resection of pancreatic cancer: A systematic review and meta-analysis. Gastroenterology. 2024;167:977\u201392.","journal-title":"Gastroenterology"},{"key":"3968_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.molcel.2007.11.026","volume":"29","author":"G Schaaf","year":"2008","unstructured":"Schaaf G, Ortlund EA, Tyeryar KR, Mousley CJ, Ile KE, Garrett TA, et al. Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the Sec14 superfamily. Mol cell. 2008;29:191\u2013206.","journal-title":"Mol cell"},{"key":"3968_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35678-4","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Pustovalova Y, Doukov TI, Hoch JC, Mains RE, Eipper BA, et al. Structure of the Sec14 domain of kalirin reveals a distinct class of lipid-binding module in rhogefs. Nat Commun. 2023;14:96.","journal-title":"Nat Commun"},{"key":"3968_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41556-021-00704-y","volume":"23","author":"B Gong","year":"2021","unstructured":"Gong B, Guo Y, Ding S, Liu X, Meng A, Li D, et al. A Golgi-derived vesicle potentiates ptdins4p to ptdins3p conversion for endosome fission. Nat Cell Biol. 2021;23:782\u201395.","journal-title":"Nat Cell Biol"},{"key":"3968_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2018.11.012","volume":"70","author":"R Costa","year":"2019","unstructured":"Costa R, Todt D, Zapatero-Belinch\u00f3n F, Schenk C, Anastasiou OE, Walker A, et al. Sec14l2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations. J Hepatol. 2019;70:603\u201314.","journal-title":"J Hepatol"},{"key":"3968_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature14899","volume":"524","author":"M Saeed","year":"2015","unstructured":"Saeed M, Andreo U, Chung HY, Espiritu C, Branch AD, Silva JM, et al. Sec14l2 enables pan-genotype HCV replication in cell culture. Nature. 2015;524:471\u20135.","journal-title":"Nature"},{"key":"3968_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09604-0","volume":"10","author":"B Gong","year":"2019","unstructured":"Gong B, Li Z, Xiao W, Li G, Ding S, Meng A, et al. Sec14l3 potentiates vegfr2 signaling to regulate zebrafish vasculogenesis. Nat Commun. 2019;10:1606.","journal-title":"Nat Commun"},{"key":"3968_CR15","doi-asserted-by":"publisher","first-page":"9807","DOI":"10.1158\/0008-5472.CAN-05-1334","volume":"65","author":"J Ni","year":"2005","unstructured":"Ni J, Wen X, Yao J, Chang HC, Yin Y, Zhang M, et al. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res. 2005;65:9807\u201316.","journal-title":"Cancer Res"},{"key":"3968_CR16","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1158\/0008-5472.CAN-11-3711","volume":"72","author":"T Geiger","year":"2012","unstructured":"Geiger T, Madden SF, Gallagher WM, Cox J, Mann M. Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res. 2012;72:2428\u201339.","journal-title":"Cancer Res"},{"key":"3968_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.omtn.2021.04.019","volume":"24","author":"DD Zhang","year":"2021","unstructured":"Zhang DD, Shi Y, Liu JB, Yang XL, Xin R, Wang HM, et al. Construction of a myc-associated cerna network reveals a prognostic signature in hepatocellular carcinoma. Mol Ther Nucleic Acids. 2021;24:1033\u201350.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3968_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02401-9","volume":"23","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Li D, Liang Y, Long Y, Liu Y. Sec14l2 regulates the transport of cholesterol in non-small cell lung cancer through scarb1. Lipids Health Dis. 2024;23:407.","journal-title":"Lipids Health Dis"},{"key":"3968_CR19","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. Gepia: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"3968_CR20","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao L, Huang C, Cui Zhou D, Hu Y, Lih TM, Savage SR, et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell. 2021;184:5031\u201352.e5026.","journal-title":"Cell"},{"key":"3968_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13045-022-01384-3","volume":"15","author":"Y Tong","year":"2022","unstructured":"Tong Y, Sun M, Chen L, Wang Y, Li Y, Li L, et al. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma. J Hematol Oncol. 2022;15:168.","journal-title":"J Hematol Oncol"},{"key":"3968_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s43018-022-00479-7","volume":"4","author":"DY Hyeon","year":"2023","unstructured":"Hyeon DY, Nam D, Han Y, Kim DK, Kim G, Kim D, et al. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an asian population reveals tumor cell-enriched and immune-rich subtypes. Nat Cancer. 2023;4:290\u2013307.","journal-title":"Nat Cancer"},{"key":"3968_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","volume":"18","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Liu W, Zhang HM, Xie GY, Miao YR, Xia M, et al. Htftarget: a comprehensive database for regulations of human transcription factors and their targets. Genomics, Proteom Bioinform. 2020;18:120\u20138.","journal-title":"Genomics, Proteom Bioinform"},{"key":"3968_CR24","doi-asserted-by":"publisher","first-page":"D154","DOI":"10.1093\/nar\/gkad1077","volume":"52","author":"IE Vorontsov","year":"2024","unstructured":"Vorontsov IE, Eliseeva IA, Zinkevich A, Nikonov M, Abramov S, Boytsov A, et al. Hocomoco in 2024: A rebuild of the curated collection of binding models for human and mouse transcription factors. Nucleic Acids Res. 2024;52:D154\u201363.","journal-title":"Nucleic Acids Res"},{"key":"3968_CR25","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.cell.2014.08.009","volume":"158","author":"MT Weirauch","year":"2014","unstructured":"Weirauch MT, Yang A, Albu M, Cote AG, Montenegro-Montero A, Drewe P, et al. Determination and inference of eukaryotic transcription factor sequence specificity. Cell. 2014;158:1431\u201343.","journal-title":"Cell"},{"key":"3968_CR26","doi-asserted-by":"publisher","first-page":"D46","DOI":"10.1093\/nar\/gkac1067","volume":"51","author":"J Huang","year":"2023","unstructured":"Huang J, Zheng W, Zhang P, Lin Q, Chen Z, Xuan J, et al. Chipbase v3.0: The encyclopedia of transcriptional regulations of non-coding RNAs and protein-coding genes. Nucleic Acids Res. 2023;51:D46\u201356.","journal-title":"Nucleic Acids Res"},{"key":"3968_CR27","doi-asserted-by":"publisher","first-page":"baq020","DOI":"10.1093\/database\/baq020","volume":"2010","author":"M Safran","year":"2010","unstructured":"Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, et al. Genecards version 3: the human gene integrator. Database: J Biol Databases Curation. 2010;2010:baq020.","journal-title":"Database: J Biol Databases Curation"},{"key":"3968_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/nar\/gkg108","volume":"31","author":"V Matys","year":"2003","unstructured":"Matys V, Fricke E, Geffers R, G\u00f6ssling E, Haubrock M, Hehl R, et al. Transfac: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003;31:374\u20138.","journal-title":"Nucleic Acids Res"},{"key":"3968_CR29","doi-asserted-by":"publisher","first-page":"D729","DOI":"10.1093\/nar\/gky1094","volume":"47","author":"R Zheng","year":"2019","unstructured":"Zheng R, Wan C, Mei S, Qin Q, Wu Q, Sun H, et al. Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019;47:D729\u201335.","journal-title":"Nucleic Acids Res"},{"key":"3968_CR30","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V, et al. Jaspar 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2024;52:D174\u201382.","journal-title":"Nucleic Acids Res"},{"key":"3968_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.659168","volume":"8","author":"Z Feng","year":"2021","unstructured":"Feng Z, Li K, Wu Y, Peng C. Transcriptomic profiling identifies dcbld2 as a diagnostic and prognostic biomarker in pancreatic ductal adenocarcinoma. Front Mol Biosci. 2021;8:659168.","journal-title":"Front Mol Biosci"},{"key":"3968_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02527-1","volume":"18","author":"Z Feng","year":"2020","unstructured":"Feng Z, Shi M, Li K, Ma Y, Jiang L, Chen H, et al. Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma. J Transl Med. 2020;18:360.","journal-title":"J Transl Med"},{"key":"3968_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1053\/j.gastro.2025.03.019","volume":"169","author":"R Tang","year":"2025","unstructured":"Tang R, Zhang Z, Liu X, Liao Y, Chen Y, Xiao M, et al. Stromal stiffness-regulated igf2bp2 in pancreatic cancer drives immune evasion via sphingomyelin metabolism. Gastroenterology. 2025;169:615\u201331.e632.","journal-title":"Gastroenterology"},{"key":"3968_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1158\/1078-0432.CCR-24-2200","volume":"31","author":"N Yamamoto","year":"2025","unstructured":"Yamamoto N, Dobersch S, Loveless I, Samraj AN, Jang GH, Haraguchi M, et al. Hmga2 expression predicts subtype, survival, and treatment outcome in pancreatic ductal adenocarcinoma. Clin Cancer Res : Off J Am Assoc Cancer Res. 2025;31:733\u201345.","journal-title":"Clin Cancer Res : Off J Am Assoc Cancer Res"},{"key":"3968_CR35","first-page":"65","volume":"8","author":"S Olsson Hau","year":"2022","unstructured":"Olsson Hau S, Wahlin S, Cervin S, Falk V, Nodin B, Elebro J, et al. Prr11 unveiled as a top candidate biomarker within the rbm3-regulated transcriptome in pancreatic cancer. The journal of pathology. Clin Res. 2022;8:65\u201377.","journal-title":"Clin Res"},{"key":"3968_CR36","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.18632\/oncotarget.23486","volume":"9","author":"E Karnevi","year":"2018","unstructured":"Karnevi E, Dror LB, Mardinoglu A, Elebro J, Heby M, Olofsson SE, et al. Translational study reveals a two-faced role of rbm3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification. Oncotarget. 2018;9:6188\u2013200.","journal-title":"Oncotarget"},{"key":"3968_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38605-3","volume":"14","author":"X Xiao","year":"2023","unstructured":"Xiao X, Shi J, He C, Bu X, Sun Y, Gao M, et al. Erk and usp5 govern pd-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nat Commun. 2023;14:2859.","journal-title":"Nat Commun"},{"key":"3968_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2009.01.041","volume":"137","author":"P Xu","year":"2009","unstructured":"Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell. 2009;137:133\u201345.","journal-title":"Cell"},{"key":"3968_CR39","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1038\/onc.2008.97","volume":"27","author":"SM Sureban","year":"2008","unstructured":"Sureban SM, Ramalingam S, Natarajan G, May R, Subramaniam D, Bishnupuri KS, et al. The translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. Oncogene. 2008;27:4544\u201356.","journal-title":"Oncogene"},{"key":"3968_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2014.05.011","volume":"351","author":"SM Sureban","year":"2014","unstructured":"Sureban SM, May R, Weygant N, Qu D, Chandrakesan P, Bannerman-Menson E, et al. Xmd8-92 inhibits pancreatic tumor xenograft growth via a dclk1-dependent mechanism. Cancer Lett. 2014;351:151\u201361.","journal-title":"Cancer Lett"},{"key":"3968_CR41","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.7150\/jca.50299","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu S, Huang D, Huang J, Yan J, Chen T, Zhang N, et al. Genome-wide expression analysis identifies the association between sec14l2 and castration-resistant prostate cancer survival. J Cancer. 2021;12:2173\u201380.","journal-title":"J Cancer"},{"key":"3968_CR42","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.foodchem.2012.09.147","volume":"138","author":"KW Tam","year":"2013","unstructured":"Tam KW, Ho CT, Lee WJ, Tu SH, Huang CS, Chen CS, et al. Alteration of \u03b1-tocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development. Food Chem. 2013;138:1015\u201321.","journal-title":"Food Chem"},{"key":"3968_CR43","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.3390\/cancers12123819","volume":"12","author":"JW Eun","year":"2020","unstructured":"Eun JW, Seo CW, Baek GO, Yoon MG, Ahn HR, Son JA, et al. Circulating exosomal microRNA-1307-5p as a predictor for metastasis in patients with hepatocellular carcinoma. Cancers. 2020;12:3819.","journal-title":"Cancers"},{"key":"3968_CR44","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.2174\/0109298673336147241010065340","volume":"32","author":"J Zheng","year":"2025","unstructured":"Zheng J, Shu D, Xu R, Zheng Y, Lin P, Lin Y, et al. Development and validation of a cholesterol-related gene signature for prognostic assessment in head and neck squamous cell carcinoma. Curr Med Chem. 2025;32:8627\u201346.","journal-title":"Curr Med Chem"},{"key":"3968_CR45","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1007\/s00018-016-2253-7","volume":"73","author":"X Zhu","year":"2016","unstructured":"Zhu X, B\u00fchrer C, Wellmann S. Cold-inducible proteins cirp and rbm3, a unique couple with activities far beyond the cold. Cell Mol Life Sci. 2016;73:3839\u201359.","journal-title":"Cell Mol Life Sci"},{"key":"3968_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41419-023-05627-0","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Lv C, Niu Y, Li C, Li X, Shang Y, et al. Rbm3 suppresses stemness remodeling of prostate cancer in the bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA. Cell Death Dis. 2023;14:91.","journal-title":"Cell Death Dis"},{"key":"3968_CR47","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s10495-023-01850-4","volume":"28","author":"Z Wang","year":"2023","unstructured":"Wang Z, Shu W, Zhao R, Liu Y, Wang H. Sodium butyrate induces ferroptosis in endometrial cancer cells via the rbm3\/slc7a11 axis. Apoptosis: Int J Program Cell Death. 2023;28:1168\u201383.","journal-title":"Apoptosis: Int J Program Cell Death"},{"key":"3968_CR48","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-12-1343","volume":"73","author":"Y Zeng","year":"2013","unstructured":"Zeng Y, Wodzenski D, Gao D, Shiraishi T, Terada N, Li Y, et al. Stress-response protein rbm3 attenuates the stem-like properties of prostate cancer cells by interfering with cd44 variant splicing. Cancer Res. 2013;73:4123\u201333.","journal-title":"Cancer Res"},{"key":"3968_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ebiom.2019.06.030","volume":"45","author":"W Dong","year":"2019","unstructured":"Dong W, Dai ZH, Liu FC, Guo XG, Ge CM, Ding J, et al. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production. EBioMedicine. 2019;45:155\u201367.","journal-title":"EBioMedicine"},{"key":"3968_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/HYPERTENSIONAHA.122.19618","volume":"80","author":"Y Xie","year":"2023","unstructured":"Xie Y, Gao R, Gao Y, Dong Z, Ge J. 11\u2009s proteasome activator reg\u03b3 promotes aortic dissection by inhibiting rbm3 (RNA binding motif protein 3) pathway. Hypertension. 2023;80:125\u201337.","journal-title":"Hypertension"},{"key":"3968_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1053\/j.gastro.2013.09.050","volume":"146","author":"JM Bailey","year":"2014","unstructured":"Bailey JM, Alsina J, Rasheed ZA, McAllister FM, Fu YY, Plentz R, et al. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology. 2014;146:245\u201356.","journal-title":"Gastroenterology"},{"key":"3968_CR52","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2019.08.018","volume":"157","author":"P Dandawate","year":"2019","unstructured":"Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, et al. The histone demethylase KDM3A, increased in human pancreatic tumors, regulates the expression of DCLK1 and promotes tumorigenesis in mice. Gastroenterology. 2019;157:1646\u201359.e1611.","journal-title":"Gastroenterology"},{"key":"3968_CR53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41589-020-0506-0","volume":"16","author":"FM Ferguson","year":"2020","unstructured":"Ferguson FM, Nabet B, Raghavan S, Liu Y, Leggett AL, Kuljanin M, et al. Discovery of a selective inhibitor of doublecortin-like kinase 1. Nat Chem Biol. 2020;16:635\u201343.","journal-title":"Nat Chem Biol"},{"key":"3968_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11870-x","volume":"10","author":"X Zhu","year":"2019","unstructured":"Zhu X, Yan J, Bregere C, Zelmer A, Goerne T, Kapfhammer JP, et al. RBM3 promotes neurogenesis in a niche-dependent manner via the IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury. Nat Commun. 2019;10:3983.","journal-title":"Nat Commun"},{"key":"3968_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32176-5","volume":"13","author":"JH Badrani","year":"2022","unstructured":"Badrani JH, Strohm AN, Lacasa L, Civello B, Cavagnero K, Haung YA, et al. RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R. Nat Commun. 2022;13:4435.","journal-title":"Nat Commun"},{"key":"3968_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2012.01.003","volume":"23","author":"C Huang","year":"2012","unstructured":"Huang C, Xie K. Crosstalk of sp1 and stat3 signaling in pancreatic cancer pathogenesis. Cytokine Growth Factor Rev. 2012;23:25\u201335.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3968_CR57","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1158\/0008-5472.CAN-06-1670","volume":"67","author":"K Jungert","year":"2007","unstructured":"Jungert K, Buck A, von Wichert G, Adler G, K\u00f6nig A, Buchholz M, et al. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res. 2007;67:1563\u201370.","journal-title":"Cancer Res"},{"key":"3968_CR58","doi-asserted-by":"publisher","first-page":"e10071.","DOI":"10.1002\/advs.202510071","volume":"12","author":"H Hang","year":"2025","unstructured":"Hang H, Yu M, Zhu L, Tang N, Fu X, Cai Z. et al. Sp1-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer. Adv Sci. 2025;12:e10071.","journal-title":"Adv Sci"},{"key":"3968_CR59","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-12-3859","volume":"73","author":"X Kong","year":"2013","unstructured":"Kong X, Li L, Li Z, Le X, Huang C, Jia Z, et al. Dysregulated expression of foxm1 isoforms drives progression of pancreatic cancer. Cancer Res. 2013;73:3987\u201396.","journal-title":"Cancer Res"},{"key":"3968_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409987","volume":"12","author":"Z Feng","year":"2025","unstructured":"Feng Z, Lou J, Lin C, Yu H, Tu Y, Gong J, et al. Unraveling the role of mdk-sdc4 interaction in pancreatic cancer-associated new-onset diabetes by single-cell transcriptomic analysis. Adv Sci. 2025;12:e09987.","journal-title":"Adv Sci"},{"key":"3968_CR61","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1158\/0008-5472.CAN-09-3282","volume":"70","author":"Z Jia","year":"2010","unstructured":"Jia Z, Gao Y, Wang L, Li Q, Zhang J, Le X, et al. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes sp1 degradation and synergistic antitumor activity. Cancer Res. 2010;70:1111\u20139.","journal-title":"Cancer Res"},{"key":"3968_CR62","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1158\/0008-5472.CAN-10-2016","volume":"71","author":"Y Gao","year":"2011","unstructured":"Gao Y, Jia Z, Kong X, Li Q, Chang DZ, Wei D, et al. Combining betulinic acid and mithramycin A effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. Cancer Res. 2011;71:5182\u201393.","journal-title":"Cancer Res"},{"key":"3968_CR63","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1158\/0008-5472.CAN-03-1945","volume":"64","author":"D Wei","year":"2004","unstructured":"Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL, Xie K. Celecoxib inhibits vascular endothelial growth factor expression and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of sp1 transcription factor activity. Cancer Res. 2004;64:2030\u20138.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03968-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03968-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03968-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:03:31Z","timestamp":1791363811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03968-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":63,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2026,10,28]]}},"alternative-id":["3968"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03968-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All human tissue research in this study obtained approval from the Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (Reference Number: 2019-447) and was performed in accordance with the Declaration of Helsinki. All participants provided informed consent. Animal experiment procedures were approved by the Lab of Experimental Ethical Inspection of Dr.Can Biotechnology (Zhejiang) Co., Ltd (Reference Number: DRK-20240601364).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}